Bacillithiol is an antioxidant compound produced by many Gram-positive bacteria including the pathogenic organisms Bacillus anthracis and Staphylococcus aureus. It is involved in the maintenance of redox homeostasis and detoxification of xenobiotic compounds, including the FDA-approved antibiotic fosfomycin. Three enzymes are responsible for the biosynthesis of bacillithiol: BshA (a glycosyltransferase), BshB (a deacetylase), and BshC (a putative cysteine ligase). Although the activities of BshA and BshB have been confirmed in vivo and in vitro, BshC activity has only been inferred in vivo, suggesting that a key component involved in cysteine ligation is missing. Structural analysis of these enzymes is only in its initial stages. The proposed research seeks to use X-ray crystallography to further characterize BshC and to determine substrate, product, or analog-bound structures of all three bacillithiol biosynthesis enzymes. These structures will demonstrate how the enzymes accommodate their substrates in their active sites and give insight into the details of their mechanisms. Functional studies will be conducted on BshA to characterize the manner in which bacillithiol acts as a feedback inhibitor. Methods to produce functional BshC enzyme will be employed, including the utilization of a Gram-positive protein expression system. Additionally, a fluorescence-based assay will be used to characterize a second ligand binding site found within the BshC structure. The knowledge gained from the proposed research will provide a foundational understanding of these enzymes and ultimately give direction to the design and characterization of inhibitors capable of disrupting bacillithiol production in an effort to combat microbial resistance to fosfomycin.

Public Health Relevance

Bacillithiol is a molecule important to the survival of several disease-causing bacteria, and it plays a key role in bacterial resistance to the antibiotic fosfomycin. Inhibiting the enzymes that produce bacillithiol will disrupt the bacteria?s metabolism and make the organism more sensitive to fosfomycin. This project seeks to determine the structures and analyze the functions of these enzymes, which will aid in the development and characterization of therapeutically beneficial inhibitors to combat fosfomycin resistance.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15GM117488-01A1
Application #
9170866
Study Section
Macromolecular Structure and Function A Study Section (MSFA)
Program Officer
Barski, Oleg
Project Start
2016-09-01
Project End
2019-08-31
Budget Start
2016-09-01
Budget End
2019-08-31
Support Year
1
Fiscal Year
2016
Total Cost
$392,863
Indirect Cost
$93,039
Name
Grand Valley State University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
059692996
City
Allendale
State
MI
Country
United States
Zip Code
49401